LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 42 filers reported holding LOXO ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $33,757,000 | -18.7% | 1,289,420 | -28.1% | 1.52% | -29.7% |
| Q2 2016 | $41,543,000 | -15.2% | 1,792,207 | 0.0% | 2.16% | -33.7% |
| Q1 2016 | $48,999,000 | -3.9% | 1,792,207 | 0.0% | 3.25% | +0.2% |
| Q4 2015 | $50,988,000 | +62.8% | 1,792,207 | 0.0% | 3.25% | +57.3% |
| Q3 2015 | $31,328,000 | -3.0% | 1,792,207 | 0.0% | 2.06% | +22.3% |
| Q2 2015 | $32,313,000 | +44.8% | 1,792,207 | 0.0% | 1.69% | +67.2% |
| Q1 2015 | $22,313,000 | +6.0% | 1,792,207 | 0.0% | 1.01% | -1.2% |
| Q4 2014 | $21,058,000 | – | 1,792,207 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
| DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
| Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
| Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
| Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
| AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
| Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
| Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
| Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |